Company news

Biotron Limited news in 2024

Biotron Limited's news releases, calls and decks from 2024, newest first.

View company

Agreement with C14 Consulting Group

November 26, 2024

$1.8M R&D Rebate Received

October 13, 2024

BIT225-012 phase 2 covid-19 clinical trial

September 5, 2024

BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives

June 19, 2024

Positive outcomes in BIT225 phase 2 clinical trial in hiv

April 4, 2024

Response to ASX Price Query

March 26, 2024

Decks in 2024